Dan Dolan | Chief Financial Officer |
Ted Schroeder | Chief Executive Officer |
Ed Arce | H.C. Wainwright |
Thank you for all for standing by and welcome to Nabriva Therapeutics First Quarter 2021 Financial Results Call. All lines have been placed in a listen-only mode until the question-and-answer session of today's conference. [Operator Instructions] I'll now turn the call over to your host, Dan Dolan. Sir, you may begin.
Thank you and good afternoon, everyone.